Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) — Accelerating adoption of healthcare IT, rising focus on patient safety, and government-backed digital health initiatives reshape global care delivery
The global clinical decision support systems (CDSS) market, valued at US$2.25 billion in 2024, stood at US$2.46 billion in 2025 and is projected to advance at a resilient CAGR of 9.6% from 2025 to 2030, culminating in a forecasted valuation of US$3.89 billion by the end of the period. This growth is fueled by surging demand for improved clinical outcomes, reduced medication errors, and seamless integration of decision support tools into electronic health record (EHR) systems.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18085342
Strategic Relevance for Healthcare Leaders
For C-suite executives across healthcare, technology, and life sciences sectors, CDSS represents a strategic lever for operational efficiency and quality-driven care. These systems leverage artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) to transform vast clinical datasets into actionable insights, enabling faster, more accurate diagnoses and treatment plans.
The timing is critical: the convergence of value-based care models, government mandates for health IT interoperability, and heightened patient safety expectations is driving investment decisions now, with long-term competitive advantage for early adopters.
Key Market Drivers
Government Regulations and Investments
Global health policies are accelerating CDSS adoption. In the US, the CMS Interoperability and Prior Authorization Rule (2024) streamlines data exchange, while Europe’s EHDS regulation (2025) fosters standardized, cross-border EHR use. France’s USD 8.34 billion Health Innovation Plan and the UK’s USD 40 million NHS tech program are strengthening digital health infrastructure and enabling AI-powered clinical insights at scale.
Emerging Market Growth Potential
Asia-Pacific is emerging as a high-growth frontier. India’s Ayushman Bharat Digital Mission (ABDM) has created over 730 million health accounts, while China’s digital healthcare market—valued at 195.4 billion CNY in 2022—has achieved EMR penetration in 90% of tertiary hospitals. These …